The lectins concanavalin A (Con A), wheat germ agglutinin (WGA), Ricinus communis agglutinin (RCA) I+II and the polycation protamine sulfate were applied directly to renal glomerular podocytes by micropuncture techniques in vivo; others received a control solution. To make visible the distribution of lectins, some rats were given fluorescein isothiocyanate-conjugated Con A. The glomeruli undergoing the micropuncture experiments were labeled and then prepared for SEM and TEM observation, in some cases also for histochemical analysis. Comparatively, the effect of application of the Con A and protamine sulfate solution by intraarterial infusion was studied. The glomeruli of a total of 100 Munich-Wistar rats were studied. Con A and WGA cause varying degrees of’retraction’ of the foot processes of the podocytes when applied using the techniques of micropuncture. Intraarterial infusion of a Con A solution, on the other hand, causes no changes in the podocytes. RCA II, applied for 10 min using micropuncture techniques, causes thickening and swelling of the foot processes as well as the formation of intercellular junctions (‘agglutination’). RCA I, on the other hand, causes no changes in the podocytes of the rat glomerulus. Glomeruli treated with the micropuncture application of the polycation protamine sulfate demonstrate largely ‘agglutination’ and only sometimes localized minimal retraction of the foot processes of the podocytes. The intraarterial infusion of protamine sulfate causes almost exclusively ‘agglutination’ of the podocyte foot processes. Retraction of the podocyte foot processes is probably a result of the active movement of the podocytes, which is in turn induced by attachment of lectines to the lectin receptors in glycocalyx of the podocyte cell membrane. Simple reduction of the polyanions in the podocyte cell membrane by protamine sulfate appears to cause only simple electrostatic interaction which then results in ‘agglutination’ of the podocyte foot processes.

This content is only available via PDF.
© 1980 S. Karger AG, Basel
1980
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.